SCHEMBL13725224

SCHEMBL13725224

O=C(O)C1Nc2cc(C(F)(F)F)ccc2C2C=CCC12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 14/20 0.63
▸ HSPA1A P0DMV8 13/20 0.63
▸ TDP1 Q9NUW8 5/20 0.63
▸ KMT2A Q03164 8/20 0.61
▸ GAPDH P04406 8/20 0.61
▸ MEN1 O00255 7/20 0.61
▸ POLB P06746 7/20 0.61
▸ BLM P54132 5/20 0.61
▸ PLA2G1B P04054 1/20 0.61
▸ MIF P14174 1/20 0.61
▸ ATG4B Q9Y4P1 1/20 0.61
▸ HSPA8 P11142 6/20 0.61
▸ MCL1 Q07820 4/20 0.60
▸ BCL2L1 Q07817 1/20 0.60
▸ L3MBTL1 Q9Y468 5/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ KDM4E B2RXH2 4/20 0.58
▸ MAPT P10636 4/20 0.58
▸ ALOX15 P16050 4/20 0.58
▸ RECQL P46063 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31492743 0.78 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL26098723 0.78 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL13186581 0.76 PTPN7 (0.73) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL16706087 0.76 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL2808722 0.73 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL3610631 0.73 CDC25B (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL2116528 0.73 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL16706084 0.72 POLB (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH
SCHEMBL15299944 0.71 GRK6 (0.73) PTPN7HSPA1ATDP1KMT2AMEN1
SCHEMBL2116061 0.69 PTPN7 (1.00) PTPN7HSPA1ATDP1KMT2AGAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA PTPN7 3898/4885HSPA1A 581/4885TDP1 3729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback